IamFluidics

IamFluidics

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $10.3M

Overview

IamFluidics is an innovative, award-winning company commercializing a unique microencapsulation platform that combines microfluidic-level precision with industrial scalability. Its core technology, IN-AIR MICROFLUIDICS™, uses liquid jets in mid-air to produce highly uniform microparticles, offering a gentle, solvent-free alternative to traditional methods like emulsification or spray drying. The company operates through a hybrid business model, offering encapsulation services, co-development partnerships, product sales, and equipment integration, targeting key challenges in biotherapeutics, cell therapy, and nutraceuticals. With ISO-certified pilot production capabilities, IamFluidics is positioned to translate formulation concepts into scalable, commercial-ready solutions.

Drug Delivery

Technology Platform

IN-AIR MICROFLUIDICS™: A chip-free microencapsulation platform that uses liquid jets in mid-air to produce highly uniform, monodisperse microparticles and microcapsules (30µm-3mm) with industrial-scale throughput. It is a gentle, solvent-free process suitable for sensitive materials like live cells and proteins.

Funding History

2
Total raised:$10.3M
Series A$8.5M
Seed$1.8M

Opportunities

The company is positioned at the convergence of major growth markets: long-acting injectables for biologics, scalable manufacturing for cell therapies, and advanced delivery for nutraceuticals.
Its versatile platform allows it to service multiple high-value sectors with a single, scalable technology, enabling diverse revenue streams through services, products, and partnerships.

Risk Factors

Key risks include the challenge of displacing established encapsulation technologies in a conservative industry, the need to prove GMP manufacturing at full commercial scale, and the execution risk associated with managing a hybrid business model (services, products, equipment) as a relatively young company.
Competition from large CDMOs and other specialty firms is significant.

Competitive Landscape

IamFluidics competes with traditional encapsulation service providers using methods like spray drying, coacervation, and emulsification, as well as other microfluidic companies (e.g., Dolomite Microfluidics, Micronit). Its key differentiator is the combination of high monodispersity (microfluidic precision) with claimed industrial scalability and gentleness for cells, a niche currently underserved by existing technologies.